Share on StockTwits

Lombard Medical (NASDAQ:EVAR) released its earnings data on Monday. The company reported ($0.86) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.52) by $0.34, AnalystRatings.NET reports.

Shares of Lombard Medical (NASDAQ:EVAR) traded up 1.75% during mid-day trading on Monday, hitting $5.80. The stock had a trading volume of 24,866 shares. The stock’s 50-day moving average is $0. and its 200-day moving average is $0.. The company’s market cap is $93.9 million.

A number of analysts have recently weighed in on EVAR shares. Analysts at Credit Suisse initiated coverage on shares of Lombard Medical in a research note on Tuesday, July 29th. They set an “outperform” rating on the stock. Finally, analysts at Jefferies Group initiated coverage on shares of Lombard Medical in a research note on Wednesday, May 21st. They set a “buy” rating and a $11.00 price target on the stock.

Lombard Medical, Inc is a medical technology company specializing in developing, manufacturing, and marketing endovascular stent-grafts.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.